FH encodes an enzyme that is part of the mitochondrial tricarboxylic acid (Krebs) cycle involved in cellular energy metabolism and appears to function as a tumor suppressor since its activity is very low or absent in tumors from individuals with HLRCC [1–6]. Here, FH is linked to hereditary leiomyomatosis and renal cell cancer.